NCT06288620

Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer

A Prospective, Open-label, Single-arm Phase II Clinical Study to Evaluate the Efficacy and Safety of Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 77 (estimated)
• Sponsor: The First Affiliated Hospital with Nanjing Medical University · Academic / Other
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Microwave Ablative (MWA) therapy, as a minimally invasive thermal therapy, has been attempted to treat breast cancer of small lesions . However, the optimal indications for MWA in the treatment of breast cancer is unknown. This prospective, open-label, single-arm phase II clinical study was conducted to evaluate the efficacy and safety of MWA in the treatment of early-stage unifocal invasive breast cancer, and to explore the immune activating effect.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
PROCEDURE	Microwave Ablation	Preoperative US-guided microwave ablation of breast cancer

Timeline

• Start date: 2024-02-25
• Primary completion: 2025-05-10
• Completion: 2025-05-30
• First posted: 2024-03-01
• Last updated: 2024-03-01

Locations

1 site across 1 country: China